| Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease M Delgado, C Abad, C Martinez, J Leceta, RP Gomariz Nature medicine 7 (5), 563-568, 2001 | 455 | 2001 |
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ... Gastroenterology 124 (4), 961-971, 2003 | 284 | 2003 |
| Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6 M Delgado, C Martinez, D Pozo, JR Calvo, J Leceta, D Ganea, ... The Journal of Immunology 162 (2), 1200-1205, 1999 | 231 | 1999 |
| Immunology of VIP: a review and therapeutical perspectives RP Gomariz, C Martinez, C Abad, J Leceta, M Delgado Current pharmaceutical design 7 (2), 89-111, 2001 | 206 | 2001 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies M Delgado, D Pozo, C Martinez, J Leceta, JR Calvo, D Ganea, ... The Journal of Immunology 162 (4), 2358-2367, 1999 | 205 | 1999 |
| Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ... Journal of molecular medicine 80, 16-24, 2002 | 204 | 2002 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages C Martínez, M Delgado, D Pozo, J Leceta, JR Calvo, D Ganea, ... Journal of leukocyte biology 63 (5), 591-601, 1998 | 180 | 1998 |
| VIP–PACAP system in immunity: new insights for multitarget therapy RP Gomariz, Y Juarranz, C ABAD, A Arranz, J Leceta, C Martinez Annals of the New York Academy of Sciences 1070 (1), 51-74, 2006 | 158 | 2006 |
| Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ... Arthritis research & therapy 7, 1-12, 2005 | 158 | 2005 |
| PACAP in immunity and inflammation M Delgado, C Abad, C Martinez, MG Juarranz, J Leceta, D Ganea, ... Annals of the New York Academy of Sciences 992 (1), 141-157, 2003 | 152 | 2003 |
| Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor C Martinez, C Abad, M Delgado, A Arranz, MG Juarranz, ... Proceedings of the National Academy of Sciences 99 (2), 1053-1058, 2002 | 151 | 2002 |
| Immunobiology of vasoactive intestinal peptide (VIP) D Pozo, M Delgado, C Martı́nez, JM Guerrero, J Leceta, RP Gomariz, ... Immunology today 21 (1), 7-11, 2000 | 143 | 2000 |
| Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes M Delgado, C Martinez, MC Johnson, RP Gomariz, D Ganea Journal of neuroimmunology 68 (1-2), 27-38, 1996 | 141 | 1996 |
| Regulation of VIP production and secretion by murine lymphocytes C Martinez, M Delgado, C Abad, RP Gomariz, D Ganea, J Leceta Journal of neuroimmunology 93 (1-2), 126-138, 1999 | 140 | 1999 |
| VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts I Gutierrez-Canas, Y Juarranz, B Santiago, A Arranz, C Martinez, ... Rheumatology 45 (5), 527-532, 2006 | 104 | 2006 |
| Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP RP Gomariz, A Arranz, C Abad, M Torroba, C Martinez, F Rosignoli, ... Journal of leukocyte biology 78 (2), 491-502, 2005 | 104 | 2005 |
| Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells MG Juarranz, B Santiago, M Torroba, I Gutierrez-Canas, G Palao, ... Rheumatology 43 (4), 416-422, 2004 | 103 | 2004 |
| Receptors and transcriptional factors involved in the anti‐inflammatory activity of VIP and PACAP J Leceta, RP Gomariz, C Martinez, C Abad, D Ganea, M Delgado Annals of the New York Academy of Sciences 921 (1), 92-102, 2000 | 103 | 2000 |
| Anti‐inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock M Delgado, RP Gomariz, C Martinez, C Abad, J Leceta European journal of immunology 30 (11), 3236-3246, 2000 | 102 | 2000 |
| VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies C Martinez, M Delgado, D Pozo, J Leceta, JR Calvo, D Ganea, ... Journal of neuroimmunology 85 (2), 155-167, 1998 | 90 | 1998 |
